We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“Contracting issues” have been delaying the implementation timeline for the new FDA gateway for electronic submissions, said Michael Fauntleroy, program manager at the FDA Gateway program and director of the electronic submissions program at the Center for Biologics Evaluation and Research (CBER).